Alpha Profiles · Company Profile

Harmony Biosciences Holdings, Inc.

Canonical company identity and public leadership record.

https://registry.alpha.ac/companies/harmony-biosciences-holdings-inc

Entity: Public listing published
Primary listing: NASDAQ: HRMY
Verification: Partially verified
Last reviewed: 2026-09-12T21:31:23.739173+00:00

Overview

Alpha's canonical identity and public leadership record for Harmony Biosciences Holdings, Inc..

Canonical AEGIS identity graph

Executive leadership

Current, confirmed roles are shown only when both the person Profile and supporting source record satisfy the public projection boundary. A missing role is not evidence that it does not exist.

Executive team

6 public records

Adam Zaeske

Chief Commercial Officer

State: confirmed
Effective: Date not stated
Confidence: 95%
Evidence: SEC DEF 14A 0001104659-26-039449Apr 3, 2026

Andrew Serafin

Chief Strategy Officer

State: confirmed
Effective: Date not stated
Confidence: 95%
Evidence: SEC DEF 14A 0001104659-26-039449Apr 3, 2026

Jeffrey M. Dayno, M.D.

President and Chief Executive Officer

State: confirmed
Effective: Date not stated
Confidence: 95%
Evidence: SEC DEF 14A 0001104659-26-039449Apr 3, 2026

Kumar Budur, M.D., M.S.

Chief Medical Officer

State: confirmed
Effective: Date not stated
Confidence: 95%
Evidence: SEC DEF 14A 0001104659-26-039449Apr 3, 2026

Peter Anastasiou

Chief Operating Officer

State: confirmed
Effective: Date not stated
Confidence: 95%
Evidence: SEC DEF 14A 0001104659-26-039449Apr 3, 2026

Sandip Kapadia

Chief Financial Officer and Chief Administrative Officer

State: confirmed
Effective: Date not stated
Confidence: 95%
Evidence: SEC DEF 14A 0001104659-26-039449Apr 3, 2026

Governance leadership

Boards & Committees

Board and committee assignments appear only when the canonical public projection retains a current role and supporting source. Unpublished records are not interpreted as absence.

Record as of Sep 12, 2026. Chair, executive office, Lead Independent Director and committee appointments retain their separate source roles. A complete board composition denominator and committee charters are not established by a partial roster.